Treatment Protocol for Bilateral Breast Cancer with Different Pathologic Biopsy Results

Diagnostic Workup

A comprehensive pathologic diagnosis should be obtained for each breast lesion via core needle biopsy before any surgical procedure, following the World Health Organization classification and TNM staging system, analyzing all tissue removed 3, 1
Each breast tumor must be individually assessed for histological type and grade, estrogen receptor (ER) and progesterone receptor (PR) status by immunohistochemistry, HER2 status, and proliferation markers such as Ki67 1, 2

Each breast cancer should be staged independently using the TNM system, with routine staging examinations including physical examination, full blood counts, and routine chemistry 3, 1
For higher-risk disease, additional imaging is recommended, including chest X-ray or CT, abdominal ultrasound or CT scan, and bone scan 1, 2

Surgical options should be evaluated for each breast independently, considering tumor size, multicentricity, tumor location, and margin status 4, 3
Axillary management should be performed for each breast separately, with breast-conserving surgery with radiation or mastectomy considered based on individual tumor characteristics 4, 3

Treatment decisions should be based on the biological characteristics of each tumor, with endocrine therapy mandatory for hormone receptor-positive tumors, and anti-HER2 therapy plus chemotherapy for HER2-positive tumors 1, 2
For triple-negative tumors, chemotherapy is the mainstay of treatment, with consideration of immunotherapy if PD-L1 positive 2

Breast radiotherapy is strongly recommended after breast-conserving surgery, with post-mastectomy radiotherapy recommended for patients with four or more positive axillary nodes or T3 tumors with positive axillary nodes 4, 3

Incomplete pathology reporting can significantly impact treatment decisions, emphasizing the need for standardized reporting for both tumors 6
Tumor heterogeneity between and within breasts may complicate treatment decisions, requiring multidisciplinary discussion 2, 7
Regular follow-up with clinical breast examination and mammography is crucial for monitoring response and detecting recurrence 1